Glenmede Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$10.4M Buy
222,136
+27,337
+14% +$1.42M 0.05% 342
2025
Q2
$10.1M Buy
+194,799
New +$10.7M 0.05% 348

Other funds holding CNMD

Glenmede Investment Management's CNMD Position: Q3 2025 in Review

Glenmede Investment Management increased its CONMED (CNMD) stake by 14% in Q3 2025, buying an estimated $1.42M and bringing the position to 222,136 shares worth $10.4M. The position accounts for 0.05% of the portfolio, ranked #342.

Glenmede Investment Management first reported a position in CNMD in Q2 2025 and has held it in 2 quarters since. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Glenmede Investment Management held 222,136 shares of CONMED worth $10.4M as of Q3 2025.
  • Glenmede Investment Management bought 27,337 CONMED shares in Q3 2025, an estimated $1.42M.
  • CONMED made up 0.05% of Glenmede Investment Management's portfolio in Q3 2025, its #342 holding.
  • Glenmede Investment Management first reported a position in CONMED in Q2 2025 and has held it in 2 quarters since.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.